DIVI S LABORATORIES LTD vs KRM AYURVEDA LIMITED

A side-by-side comparison of DIVI S LABORATORIES LTD (DIVISLAB) and KRM AYURVEDA LIMITED (KRMAYURVED) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

DIVI S LABORATORIES LTD vs KRM AYURVEDA LIMITED are evenly matched on the numbers (7–7). The breakdown below shows where each one wins.

  • Valuation13
  • Profitability22
  • Growth02
  • Size & financial health40
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

KRMAYURVED takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

94.49
P/E ratio
0.37
10.62
P/B ratio
4.98
0.33%
Dividend yield
0.00%
₹96.73
EPS
₹806.67

Profitability

Even

How efficiently each company turns capital and sales into profit. Higher is better.

16.50%
Return on equity
29.00%
22.00%
Return on capital
42.00%
33.00%
EBITDA margin
25.00%
24.32%
Net margin
15.58%

Growth

KRMAYURVED takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.78%
Revenue CAGR (3Y)
14.92%
12.10%
Profit CAGR (3Y)
87.77%

Size & financial health

DIVISLAB takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹2.43L Cr
Market cap
₹600 Cr
₹10,560 Cr
Revenue
₹77 Cr
₹2,568 Cr
Net profit
₹12 Cr
0.00
Debt / equity
1.28
DIVI S LABORATORIES LTD
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 39.0%"]
  • ["Stock is trading at 14.6 times its book value", "The company has delivered a poor sales growth of 8.67% over past five years."]
KRM AYURVEDA LIMITED
  • + ["Company has reduced debt.", "Company is almost debt free.", "Company has a good return on equity (ROE) track record: 3 Years ROE 36.7%"]
  • ["Though the company is reporting repeated profits, it is not paying out dividend", "Debtor days have increased from 56.5 to 81.6 days.", "Working capital days have increased from 131 days to 280 days"]
DIVI S LABORATORIES LTD full analysis KRM AYURVEDA LIMITED full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

DIVISLAB vs KRMAYURVED: Share Price, Valuation & Which to Buy | DocStoX